September 2020 Feature: Gene Therapy Read this Issue
-
Gene therapy has the potential to be a “one-and-done” treatment for rare, inherited retinal disorders and potentially for disorders -
With options for CRISPR gene editing in the works, experts are excited about its potential application to Fuchs dystrophy... -
Stem cell-derived therapies for corneal and retinal conditions are in clinical trials in the U.S.
Supplements View Archives: CME Non-CME
-
MAY 2019: Innovations advancing cataract surgery -
OCT 2018: Identifying the underlying causes of ocular surface disease for more accurate diagnosis and treatment -
APR 2018: Updates to the LenSx Laser and WaveLight Refractive Suite improving the user experience -
MAY 2017: Innovative Technologies Designed to Meet the Needs of Surgeons and their Patients -
MAY 2016: Innovative IOL technologies for the cataract surgeon -
MAY 2016: 3-2-1 Action ... Live from Atlanta
